NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-187-2009-2-US-02 Organic Compounds US National Stage 13/810,587 9066948 Abandoned PDF
NCI E-136-2012-0-PCT-02 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof PCT PCT PCT/US2013/043633 Expired
NCI E-136-2012-0-JP-08 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof JP DIV 2019-000195 Pending
NCI E-039-2011-0-FR-08 Chimeric Rabbit/Human ROR1 Antibodies FR EP 11791733.6 Issued
NCI E-039-2011-0-DE-07 Chimeric Rabbit/Human ROR1 Antibodies DE EP 11791733.6 Issued
NCI E-039-2011-0-IT-09 Chimeric Rabbit/Human ROR1 Antibodies IT EP 11791733.6 Issued
NCI E-039-2011-0-GB-11 Chimeric Rabbit/Human ROR1 Antibodies GB EP 11791733.6 Issued
NCI E-039-2011-0-ES-10 Chimeric Rabbit/Human ROR1 Antibodies ES EP 11791733.6 Issued
NIA E-146-1993-0-US-57 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 13/904,928 Abandoned
NIDDK E-194-2012-0-PCT-02 Eukaryotic Transposase Mutants And Transposon End Compositions For Modifying Nucleic Acids And Methods For Production And Use In The Generation Of Sequencing Libraries PCT PCT PCT/US13/043138 Expired
NIDCR E-015-2002-1-US-08 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1 US CON 13/903,820 9347935 Expired PDF
NINDS E-251-2005-1-US-04 Vibro-tactile Stimulation To The Neck To Enhance Volitional Control Of Swallowing, Speech Or Voice In Patients With Motor Control Disorders US CON 13/902,263 8852074 Issued PDF
NIA E-139-2012-2-CA-03 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES CA National Stage 2874655 Issued
NIA E-139-2012-2-AU-02 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES AU National Stage 2013266235 Issued
NIA E-139-2012-2-EP-04 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES EP National Stage 13727753.9 Issued
NIA E-139-2012-2-PCT-01 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES PCT PCT COMB PCT/US2013/042457 Expired
NCI E-113-2003-1-US-04 Target Activated Microtransfer US CON 13/901,394 Abandoned
NCI E-105-2012-0-CA-04 Murine Anti-NY-ESO-1 T Cell Receptors CA National Stage 2874486 Issued
NCI E-105-2012-0-EP-06 Murine Anti-NY-ESO-1 T Cell Receptors EP National Stage 13726389.3 Issued
NCI E-105-2012-0-AU-03 Murine Anti-NY-ESO-1 T Cell Receptors AU National Stage 2013266421 Issued
NCI E-105-2012-0-PCT-02 Murine Anti-NY-ESO-1 T Cell Receptors PCT PCT PCT/US2013/042162 Expired
NCI E-125-2011-2-US-02 Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use US National Stage 13/988,696 9441048 Issued PDF
NCI E-003-2006-0-US-05 Antibodies and Immunotoxins that Target Human Glycoprotein NMB US DIV 13/897,587 9115196 Issued PDF
NINR E-349-2013-1-US-01 ALTERED EXPRESSION OF MIRNA AND MRNA FOR IDENTIFICATION AND THERAPY IN
DIGESTIVE AND LIVER DISORDERS 		US 61/825,489 Abandoned
NINR E-349-2013-0-US-01 Altered Expression Of Mirna And Mrna For Identification And Therapy In Digestive And Liver Disorders US 61/825,154 Abandoned
NIAID E-089-2002-1-US-48 Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 US REISSUE 13/896,388 46641 Expired PDF
NIAID E-089-2002-1-US-47 Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 US REISSUE 13/896,384 46631 Issued PDF
NIDDK E-284-2008-0-US-08 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists US CON 13/897,330 9187457 Issued PDF
NIAID E-120-2001-0-US-37 Recombinant Attenuated Dengue Viruses Comprising A Deletion in the 3' Untranslated Region and Additional Attenuating Mutations Induced by Chemical Mutagenesis US REISSUE 13/896,409 45123 Expired PDF
NIAID E-120-2001-0-US-35 Attenuated Dengue Virus Comprising Mutations in the NS3 Gene US REISSUE 13/896,411 045053 Expired PDF
NIAID E-120-2001-0-US-36 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US REISSUE 13/896,396 45016 Expired PDF
NCI E-164-2012-0-PCT-02 Nanoparticles with Enhanced Entry into Cancer Cells PCT PCT PCT/US2013/041542 Expired
NCI E-005-2011-0-US-01 SOLUBLE CD27 (SCD27) AND THE USE THEREOF US 61/824,898 Abandoned
NIAID E-139-2006-0-US-12 Development Of Dengue Virus Vaccine Components US REISSUE 13/895,908 046042 Issued PDF
NEI E-056-2008-0-US-04 MIR 204, MIR 211, Their Anti-MIRS, and Therapeutic Uses of Same US DIV 13/895,557 8710026 Issued PDF
NCI E-093-2013-0-US-01 Compounds For Inhibiting Drug-Resistant Strains Of HIV-1 Integrase US 61/824,306 Abandoned
NCI E-273-2011-0-PCT-02 Cross-Reactive Antibodies Against Dengue Viruses And Uses Thereof PCT PCT PCT/US13/40966 Expired
NCI E-025-2011-2-US-03 Antibodies To Tumor Endothelial Marker 8 US National Stage 13/884,899 9309322 Issued PDF
NIAID E-214-2015-0-CA-08 Conformationally Specific Viral Immunogens CA National Stage 2873048 Issued
NIAID E-214-2015-0-EP-06 Conformationally Specific Viral Immunogens EP National Stage 13787969.8 Issued
NIAID E-214-2015-0-PCT-03 Conformationally Specific Viral Immunogens PCT PCT PCT/US2013/040228 Expired
NIAID E-214-2015-0-US-04 Conformationally Specific Viral Immunogens US ORD 13/890,465 Abandoned
NIA E-260-2011-0-US-02 SYNTHESIS OF FLUOROARACHIDONIC AND METHODS OF USE THEREOF US National Stage 13/890,884 Abandoned
NCI E-194-2000-0-US-06 Viral Chemokine-Antigen Fusion Proteins US DIV 13/890,502 Abandoned
NIAID E-214-2015-0-US-01 Conformationally Stabilized RSV Pre-Fusion F Proteins US 61/644,830 Abandoned
NIAID E-136-2013-0-US-01 DEVELOPMENT AND CHARACTERIZATION OF LLAMA-DERIVED SINGLE- CHAIN ANTIBODY FRAGMENTS DIRECTED TO NOROVIRUS GI.1 AND GII.4 WITH POTENTIAL AS ORAL THERAPY FOR HUMAN NOROVIRUS DIARRHEA US 61/821,354 Abandoned
NIAAA E-258-2012-0-US-08 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation US CON 15/403,982 10478415 Issued PDF
NIAAA E-258-2012-0-US-07 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation US National Stage 14/440,634 9579302 Issued PDF
NIAID E-214-2015-0-US-02 Conformationally Specific Viral Immunogens US ORD 13/890,226 Abandoned
NCI E-118-2013-0-US-01 Mesothelin-Specific Immunocytokine and Use Thereof US 61/820,543 Abandoned